Placental C19MC microRNAs inhibit insulin signaling in primary human skeletal muscle
Authors:
- Imad SoukarISImad Soukar
- Tomoko Kaneko-TaruiTKTomoko Kaneko-Tarui
- Taylor FarrellTFTaylor Farrell
- Luigi BouchardLBLuigi Bouchard
- Alexander SoukasASAlexander Soukas
- Marie-France HivertMHMarie-France Hivert
- Perrie F. O'TIerney-GinnPOPerrie F. O'TIerney-Ginn
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The expression of chromosome 19 miRNA cluster members during insulin sensitivity changes in pregnancyPlacenta, 2025
- Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetesNature Medicine, 2024
- The Placental Role in Gestational Diabetes Mellitus: A Molecular PerspectivetouchREVIEWS in Endocrinology, 2024
- First trimester plasma microRNAs levels predict Matsuda Index-estimated insulin sensitivity between 24th and 29th week of pregnancyBMJ Open Diabetes Research & Care, 2022
- CellProfiler 4: improvements in speed, utility and usabilityBMC Bioinformatics, 2021
- Longitudinal changes in glucose metabolism in women with gestational diabetes, from late pregnancy to the postpartum periodDiabetologia, 2019
- Chromosome 19 microRNAs exert antiviral activity independent from type III interferon signalingPlacenta, 2018
- The primate-specific microRNA gene cluster (C19MC) is imprinted in the placentaHuman Molecular Genetics, 2010
- A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administrationBiochemical Journal, 2005
- Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.Journal of Clinical Investigation, 1992